Raymond James Financial Inc. bought a new position in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,072,040 shares of the company's stock, valued at approximately $18,257,000. Raymond James Financial Inc. owned about 0.62% of BrightSpring Health Services at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of the business. BNP Paribas Financial Markets lifted its holdings in BrightSpring Health Services by 5.0% in the third quarter. BNP Paribas Financial Markets now owns 21,329 shares of the company's stock valued at $313,000 after acquiring an additional 1,011 shares during the period. Rhumbline Advisers increased its position in BrightSpring Health Services by 1.5% during the 4th quarter. Rhumbline Advisers now owns 73,583 shares of the company's stock worth $1,253,000 after purchasing an additional 1,118 shares in the last quarter. R Squared Ltd purchased a new stake in BrightSpring Health Services during the 4th quarter worth about $74,000. Charles Schwab Investment Management Inc. increased its position in BrightSpring Health Services by 1.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 440,335 shares of the company's stock worth $6,464,000 after purchasing an additional 6,326 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in BrightSpring Health Services by 0.6% during the 3rd quarter. Geode Capital Management LLC now owns 1,304,214 shares of the company's stock worth $19,150,000 after purchasing an additional 7,750 shares in the last quarter.
Analysts Set New Price Targets
A number of analysts recently commented on the company. Wells Fargo & Company lifted their price objective on BrightSpring Health Services from $17.00 to $21.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 27th. Bank of America lifted their price objective on BrightSpring Health Services from $19.00 to $21.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. CJS Securities assumed coverage on BrightSpring Health Services in a research note on Thursday, December 12th. They issued an "outperform" rating and a $27.00 price objective on the stock. Morgan Stanley boosted their price target on BrightSpring Health Services from $19.00 to $20.00 and gave the stock an "overweight" rating in a research report on Tuesday, December 17th. Finally, UBS Group upped their target price on BrightSpring Health Services from $22.00 to $30.00 and gave the company a "buy" rating in a research report on Wednesday, January 29th. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $21.67.
Check Out Our Latest Stock Report on BrightSpring Health Services
BrightSpring Health Services Trading Up 0.2 %
Shares of BTSG opened at $17.45 on Tuesday. The stock has a fifty day moving average price of $20.03 and a two-hundred day moving average price of $17.75. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. BrightSpring Health Services, Inc. has a 52-week low of $8.60 and a 52-week high of $24.82. The company has a market cap of $3.05 billion, a price-to-earnings ratio of -67.12 and a beta of 2.20.
BrightSpring Health Services Profile
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
